These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30513520)

  • 21. A case of autosomal dominant polycystic kidney disease with amelioration of refractory cyst infections following prolonged hemodialysis time.
    Ieiri N; Hotta O
    CEN Case Rep; 2021 Nov; 10(4):598-602. PubMed ID: 34138451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease.
    Suwabe T; Ubara Y; Higa Y; Nakanishi S; Sogawa Y; Nomura K; Nishimura H; Hoshino J; Sawa N; Katori H; Takemoto F; Nakamura M; Tomikawa S; Hara S; Takaichi K
    Nephron Clin Pract; 2009; 112(3):c157-63. PubMed ID: 19390216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease.
    Bleeker-Rovers CP; de Sévaux RG; van Hamersvelt HW; Corstens FH; Oyen WJ
    Am J Kidney Dis; 2003 Jun; 41(6):E18-21. PubMed ID: 12776306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Infectious complications in autosomal dominant polycystic kidney disease].
    Pirson Y; Kanaan N
    Nephrol Ther; 2015 Apr; 11(2):73-7. PubMed ID: 25733396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.
    Akihisa T; Ino A; Egawa H; Kotera Y; Ariizumi S; Oomori A; Yamashita S; Yamamoto Y; Tsuchiya K; Yamamoto M; Nitta K; Mochizuki T
    CEN Case Rep; 2018 Nov; 7(2):307-312. PubMed ID: 29956096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiome of infected cysts, feces and saliva in patients with autosomal dominant polycystic kidney disease.
    Suwabe T; Morita H; Khasnobish A; Araoka H; Hoshino J
    CEN Case Rep; 2023 Aug; 12(3):304-310. PubMed ID: 36574197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
    Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
    Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AA-amyloidosis in autosomal dominant polycystic kidney disease caused by chronic cyst infections lasting for 30 years.
    Tsuchiya Y; Ubara Y; Suwabe T; Nomura K; Sumida K; Hiramatsu R; Hoshino J; Hasegawa E; Yamanouchi M; Hayami N; Sawa N; Takaichi K; Oohashi K
    Intern Med; 2013; 52(7):791-4. PubMed ID: 23545677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease.
    Bobot M; Ghez C; Gondouin B; Sallée M; Fournier PE; Burtey S; Legris T; Dussol B; Berland Y; Souteyrand P; Tessonnier L; Cammilleri S; Jourde-Chiche N
    Clin Microbiol Infect; 2016 Jan; 22(1):71-77. PubMed ID: 26454062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of renal cyst infection in patients with autosomal dominant polycystic kidney disease: a systematic review.
    Lantinga MA; Casteleijn NF; Geudens A; de Sévaux RG; van Assen S; Leliveld AM; Gansevoort RT; Drenth JP;
    Nephrol Dial Transplant; 2017 Jan; 32(1):144-150. PubMed ID: 26908766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep-Disordered Breathing in Patients with Polycystic Liver and Kidney Disease Referred for Transcatheter Arterial Embolization.
    Sumida K; Hoshino J; Suwabe T; Kasai T; Hayami N; Mise K; Kawada M; Imafuku A; Hiramatsu R; Hasegawa E; Yamanouchi M; Sawa N; Narui K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):949-56. PubMed ID: 25825485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary peritonitis due to liver cyst rupture in autosomal dominant polycystic kidney disease.
    Matsuo H; Katayama K; Hayasaki A; Iizawa Y; Endo M; Murata T; Mizuno S; Dohi K
    BMC Gastroenterol; 2021 Jun; 21(1):267. PubMed ID: 34167461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver involvement in early autosomal-dominant polycystic kidney disease.
    Hogan MC; Abebe K; Torres VE; Chapman AB; Bae KT; Tao C; Sun H; Perrone RD; Steinman TI; Braun W; Winklhofer FT; Miskulin DC; Rahbari-Oskoui F; Brosnahan G; Masoumi A; Karpov IO; Spillane S; Flessner M; Moore CG; Schrier RW
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):155-64.e6. PubMed ID: 25111236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life-Threatening Retroperitoneal Hemorrhage Following Cyst Rupture in Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Case Report.
    Duriseti P; Radhakrishnan Y; Chedid M; Hanna C; Potrezke TA; Chebib FT
    Am J Case Rep; 2023 Feb; 24():e938889. PubMed ID: 36843311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case report of a pyogenic liver abscess caused by Fusobacterium nucleatum in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis.
    Cigarrán S; Neches C; Lamas JM; García-Trio G; Alonso M; Saavedra J
    Ther Apher Dial; 2008 Feb; 12(1):91-5. PubMed ID: 18257820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney Transplantation After Renal Transcatheter Arterial Embolization for Cyst Infection in a Hemodialysis Patient With Autosomal Dominant Polycystic Kidney Disease: A Case Report.
    Iguchi K; Iwai T; Kosoku A; Nishide S; Kabei K; Kumada N; Uchida J
    Transplant Proc; 2023 May; 55(4):1065-1067. PubMed ID: 37121861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
    Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
    J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 18F-FDG PET/CT demonstrated renal and hepatic cyst infection in a patient with autosomal dominant polycystic kidney disease.
    Albano D; Bosio G; Bertagna F
    Nucl Med Rev Cent East Eur; 2016; 19(B):26-28. PubMed ID: 27813615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study.
    Park H; Paek JH; Kim Y; Park WY; Han S; Jin K
    Medicine (Baltimore); 2022 Nov; 101(47):e31838. PubMed ID: 36451428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.